Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Brady

Showing results (591-600 of 605) with videos related to

Pageof 61
Sort By:
Nature Communications|February 13, 2021
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasmsJason R Schwartz, Jing Ma, Jennifer Kamens, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Combining Mass Spectrometry with Machine Learning to Identify Novel Protein Signatures: The Example of Multisystem Inflammatory Syndrome in ChildrenJeisac Guzmán Rivera, Haiyan Zheng, Benjamin Richlin, et al.
Scientific Reports|October 22, 2025
Mass spectrometry combined with machine learning identifies novel protein signatures as demonstrated with multisystem inflammatory syndrome in childrenJeisac Guzmán Rivera, Haiyan Zheng, Benjamin Richlin, et al.
Nature Communications|November 10, 2021
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastomaMin Pan, William C Wright, Richard H Chapple, et al.
Scientific Reports|June 12, 2026
Antibody repertoire associated with clinically diverse presentations of pediatric SARS-CoV-2 infectionNatalie Bruiners, Rahul Ukey, Katherine C Konvinse, et al.
Nature Communications|November 3, 2017
Combating subclonal evolution of resistant cancer phenotypesSamuel W Brady, Jasmine A McQuerry, Yi Qiao, et al.
Blood|January 26, 2026
Uncovering the genomic complexity of PAX5 intragenic tandem multiplication via long-read and short-read sequencingYanling Liu, Bensheng Ju, Li Dong, et al.
Nature Communications|February 7, 2018
Publisher Correction: Combating subclonal evolution of resistant cancer phenotypesSamuel W Brady, Jasmine A McQuerry, Yi Qiao, et al.
Cell Genomics|November 17, 2022
Uncovering novel mutational signatures by <i>de novo</i> extraction with SigProfilerExtractorS M Ashiqul Islam, Marcos Díaz-Gay, Yang Wu, et al.
Journal of the American Chemical Society|March 19, 2021
Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic ToxicitiesFarrukh Vohidov, Jannik N Andersen, Kyriakos D Economides, et al.
Pageof 61

Showing results (591-600 of 605) with videos related to

Sort By:
Pageof 61
Nature Communications|February 13, 2021
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasmsJason R Schwartz, Jing Ma, Jennifer Kamens, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Combining Mass Spectrometry with Machine Learning to Identify Novel Protein Signatures: The Example of Multisystem Inflammatory Syndrome in ChildrenJeisac Guzmán Rivera, Haiyan Zheng, Benjamin Richlin, et al.
Scientific Reports|October 22, 2025
Mass spectrometry combined with machine learning identifies novel protein signatures as demonstrated with multisystem inflammatory syndrome in childrenJeisac Guzmán Rivera, Haiyan Zheng, Benjamin Richlin, et al.
Nature Communications|November 10, 2021
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastomaMin Pan, William C Wright, Richard H Chapple, et al.
Scientific Reports|June 12, 2026
Antibody repertoire associated with clinically diverse presentations of pediatric SARS-CoV-2 infectionNatalie Bruiners, Rahul Ukey, Katherine C Konvinse, et al.
Nature Communications|November 3, 2017
Combating subclonal evolution of resistant cancer phenotypesSamuel W Brady, Jasmine A McQuerry, Yi Qiao, et al.
Blood|January 26, 2026
Uncovering the genomic complexity of PAX5 intragenic tandem multiplication via long-read and short-read sequencingYanling Liu, Bensheng Ju, Li Dong, et al.
Nature Communications|February 7, 2018
Publisher Correction: Combating subclonal evolution of resistant cancer phenotypesSamuel W Brady, Jasmine A McQuerry, Yi Qiao, et al.
Cell Genomics|November 17, 2022
Uncovering novel mutational signatures by <i>de novo</i> extraction with SigProfilerExtractorS M Ashiqul Islam, Marcos Díaz-Gay, Yang Wu, et al.
Journal of the American Chemical Society|March 19, 2021
Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic ToxicitiesFarrukh Vohidov, Jannik N Andersen, Kyriakos D Economides, et al.
Pageof 61